ITALY, NATIONWIDE, PROSPECTIVE, OBSERVATIONAL, MULTICENTER STUDY IN PATIENTS WITH FIRST-LINE NIVOLUMAB PLUS IPILIMUMAB THERAPY FOR LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

Copyright © 2023 FULLCRO S.R.L. - TUTTI I DIRITTI RISERVATI - P. IVA 12073321007
per contatti riguardanti lo Studio FINN FINN@fullcro.org